Perceptual Disorders: Clinical Trials

22 trials for Perceptual Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

22 terminated. 22 Phase 2, 4 Phase 3, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 222Terminated 22
Phase 34Terminated 4
Phase 12Terminated 2

Follow Perceptual Disorders: new trials by email Literature Review of Perceptual Disorders trials Research Report on Perceptual Disorders

Trials (filtered) newest first · largest first

All 22 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy
Oxycodone, Acetaminophen, Ketamine - Pain Management, Opioid Use
Phase 2 / Phase 3TerminatedWake Forest University Health Sciences582023-04-182026-06-15
MR-Guided Adaptive SBRT of Primary Tumor for Pain Control in Metastatic PDAC
SBRT, SOC chemotherapy - Pancreatic Cancer
Phase 2TerminatedLudwig-Maximilians - University of Munich92021-12-152025-12-05
Non-Opioid Pain Medications After Intracapsular Adenotonsillectomy
Oxycodone, Ibuprofen, Acetaminophen - Adenotonsillectomy, Post-operative Analgesia
Phase 1 / Phase 2TerminatedDavid Chi, MD732021-04-132024-08-30
Buprenorphine Plus Baclofen to Increase Analgesia in Healthy Volunteers
Placebos, Baclofen 5 mg, Baclofen 10mg - Acute Pain, Analgesia
Phase 2 / Phase 3TerminatedUniversity of Alabama at Birmingham192021-01-212026-01-07
Paracervical Injection for Headache in the Emergency Department
Paracervical injection, prochlorperazine and diphenhydramine.(Standard Treatment) - Headache Disorders, Primary, Pain Management
Phase 2TerminatedChristian Fromm, MD192020-09-152024-08-01
Non-opioids for Analgesia After Adenotonsillectomy in Children
Oxycodone, Ibuprofen, Acetaminophen - Adenotonsillectomy, Post-operative Analgesia
Phase 1 / Phase 2TerminatedDavid Chi, MD2682018-10-252021-11-10
Efficacy and Safety of Dexmedetomidine During Weaning From Analgesia and Sedation in PICU (TIP-15-01)
Dexmedetomidine, Placebo - Withdrawal Syndrome
Phase 2TerminatedIRCCS Azienda Ospedaliero-Universitaria di Bologna452018-08-302021-11-02
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Nelotanserin - Lewy Body Dementia, Dementia With Lewy Bodies
Phase 2TerminatedAxovant Sciences Ltd.802016-10-202019-03-27
Injecting Botulinum Toxin A Underneath the Skin to Treat Spinal Cord Pain in Patients With Spinal Cord Injury
Botulinum Toxin A, Placebo - Neuropathic Back Pain, Spinal Cord Injury
Phase 2TerminatedIcahn School of Medicine at Mount Sinai82016-03-012019-04-09
Sublingual Fentanyl for the Management of Breakthrough Pain
Fentanyl Sublingual Spray (FSS), Questionnaires, Mental Ability Tests - Advanced Cancers
Phase 2TerminatedM.D. Anderson Cancer Center62016-02-022021-05-18
Placebo-Controlled Evaluation of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy
Intranasal Dexmedetomidine, Intranasal Placebo - Pain, Post-operative
Phase 2TerminatedBaudax Bio952014-06-012015-12-10
Randomized Controlled Trial of Ketamine Infusion With Continuous Epidural Infusion for Treatment of Complex Regional Pain Syndrome
Ketamine Infusion + Epidural Infusion, Control Group + Epidural infusion, Ketamine Booster Infusion - Complex Regional Pain Syndrome
Phase 2TerminatedHospital for Special Surgery, New York32014-03-242018-01-31
Inhaled Nitrous Oxide and Labor Analgesia
Inhaled nitrous oxide - Labor Pain
Phase 2TerminatedYa'aqov Abrams162012-02-012017-11-21
A Trial in Painful Diabetic Peripheral Neuropathy With GRT3983Y
GRT3938Y, Placebo - Painful Diabetic Neuropathy
Phase 2TerminatedGrĂ¼nenthal GmbH5532009-11-012019-10-28
Intraarticular Ozone Therapy for Pain Control in Osteoarthritis of the Knee
ozone-oxygen mixture, placebo (saline) - Osteoarthritis of the Knee
Phase 2TerminatedBen-Gurion University of the Negev202009-08-012016-07-28
AZD2066 Neuropathic Pain - Mechanical Hypersensitivity
AZD2066, Placebo - Neuropathic Pain, Mechanical Hypersensitivity
Phase 2TerminatedAstraZeneca872009-08-012012-09-27
Analgesic Efficacy and Safety Study of T-62 in Subjects With Postherpetic Neuralgia
T-62 Dose 1, T-62 Dose 2, Placebo - Postherpetic Neuralgia
Phase 2TerminatedPfizer192008-12-012012-06-08
Post-Operative Pain Scores and Analgesic Requirements After Elective Inguinal Herniorrhaphy
Gabapentin, placebo - Pain, Analgesia
Phase 2 / Phase 3TerminatedUniversity of Oklahoma52008-11-062017-04-28
Effect of Spinal Ketorolac After Acute Opioid Exposure
ketorolac, placebo, remifentanil - Healthy
Phase 2TerminatedWake Forest University302007-12-012018-09-07
A Comparison of Analgesic Efficacy Between a Single Dose of ORG 28611, Morphine, and Placebo After Dental Impaction Surgery (Study P05800)
Org 28611, morphine sulfate, Placebo - Analgesia
Phase 2TerminatedMerck Sharp & Dohme LLC112007-07-012015-09-14

Showing 20 of 22. Sign in to see all of them.

Narrower conditions

Agnosia (21)  ·  Pain (7)  ·  Neuralgia (5)  ·  Pain, Postoperative (4)  ·  Complex Regional Pain Syndromes (2)  ·  Acute Pain (1)  ·  Bunion (1)  ·  Causalgia (1)  ·  Chronic Pain (1)  ·  Diabetic Neuropathies (1)  ·  Emergencies (1)  ·  Hallucinations (1)  ·  Headache Disorders, Primary (1)  ·  Hernia, Inguinal (1)  ·  Herpes Zoster (1)

Broader conditions

Nervous System Diseases (22)  ·  Neurobehavioral Manifestations (22)  ·  Neurologic Manifestations (22)  ·  Pathological Conditions, Signs and Symptoms (22)  ·  Signs and Symptoms (22)  ·  Neuromuscular Diseases (6)  ·  Pain (6)  ·  Pathologic Processes (6)  ·  Peripheral Nervous System Diseases (6)  ·  Postoperative Complications (4)  ·  Central Nervous System Diseases (3)  ·  Neoplasms (3)  ·  Autonomic Nervous System Diseases (2)  ·  Brain Diseases (2)

Interventions

Acetaminophen (3)  ·  Oxycodone (3)  ·  Ibuprofen (2)  ·  Ketamine (2)  ·  Ketorolac (2)  ·  Sodium Chloride (2)  ·  AZD2066 (1)  ·  Baclofen (1)  ·  Botulinum Toxins, Type A (1)  ·  Capsaicin (1)  ·  Control Groups (1)  ·  Dexmedetomidine (1)  ·  Entonox (1)  ·  Fentanyl (1)  ·  Gabapentin (1)

Sponsors

David Chi, MD (2)  ·  AstraZeneca (1)  ·  Axovant Sciences Ltd. (1)  ·  Baudax Bio (1)  ·  Ben-Gurion University of the Negev (1)  ·  Christian Fromm, MD (1)  ·  GrĂ¼nenthal GmbH (1)  ·  Hospital for Special Surgery, New York (1)  ·  IRCCS Azienda Ospedaliero-Universitaria di Bologna (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  Ludwig-Maximilians - University of Munich (1)  ·  M.D. Anderson Cancer Center (1)  ·  Mashhad University of Medical Sciences (1)  ·  Merck Sharp & Dohme LLC (1)  ·  National Institute of Nursing Research (NINR) (1)

Countries

United States (17)  ·  Germany (1)  ·  Israel (1)  ·  Italy (1)  ·  Switzerland (1)

Top investigators

David H Chi, MD (2)  ·  Ashok Hemal, MD (1)  ·  Badie Mansour, MD (1)  ·  Biljana Lilja (1)  ·  Brett Stacey (1)  ·  Christian Fromm, MD (1)  ·  Daniel I Richman, MD (1)  ·  Howard B Tandeter, MD (1)  ·  Ilise Lombardo, MD (1)  ·  James C. Eisenach, M.D. (1)  ·  Karen L Cropsey, Psy.D. (1)  ·  Leorey Saligan, PhD, CRNP (1)  ·  Maria C. Mondardini, MD (1)  ·  Maximilian Niyazi, Prof. Dr. (1)  ·  Neil Singla, MD (1)

Results publications

PMID 28157809, PMID 31829274, PMID 34882826, PMID 35078490, PMID 40396501

NIH funding

P30CA012197 (1)